1996
DOI: 10.1016/0264-410x(95)00242-s
|View full text |Cite
|
Sign up to set email alerts
|

Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's diseases in specific-pathogen-free chickens

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
27
0

Year Published

1999
1999
2020
2020

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 93 publications
(28 citation statements)
references
References 31 publications
0
27
0
Order By: Relevance
“…In the poultry industry, four recombinant viruses (rFPV [1,5,8,14,18,25,31,34,35,59], rHVT [13,17,28,41,44,53], adenovirus [51], and rMDV1 [45,47,49,54,62]) that express foreign antigens of other avian pathogens (including NDV [14, 17, 24, 28-30, 35, 47, 53, 58], MDV [31,33,42,44,69], infectious bursal disease virus [1,5,13,18,19,51,62], avian influenza virus [2,3,5,56,59,61,65,66], avian leukosis virus [34], and avian reticuloendotheliosis virus [8]) have been developed, and these viruses showed significant vaccine efficacy against a variety of avian diseases. Further, rHVT, rMDV1, and rFPV expressing NDV antigens have been constructed and used to FIG.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In the poultry industry, four recombinant viruses (rFPV [1,5,8,14,18,25,31,34,35,59], rHVT [13,17,28,41,44,53], adenovirus [51], and rMDV1 [45,47,49,54,62]) that express foreign antigens of other avian pathogens (including NDV [14, 17, 24, 28-30, 35, 47, 53, 58], MDV [31,33,42,44,69], infectious bursal disease virus [1,5,13,18,19,51,62], avian influenza virus [2,3,5,56,59,61,65,66], avian leukosis virus [34], and avian reticuloendotheliosis virus [8]) have been developed, and these viruses showed significant vaccine efficacy against a variety of avian diseases. Further, rHVT, rMDV1, and rFPV expressing NDV antigens have been constructed and used to FIG.…”
Section: Discussionmentioning
confidence: 99%
“…(i) The viruses induce lifetime protection against MD with just one vaccination (39), (ii) the viruses have a natural host range limited to avian species, and therefore, the vectors would be safe for other domestic animals and people working in the poultry industry, and (iii) techniques for generating recombinant MDVs have been well established (45,49). Among the vaccine viruses, HVT has been used worldwide both as live vaccine and polyvalent vaccine vector (13,17,28,29,41,42,53). However, attenuated MDV1 strains, such as C/R6 (G. F. de Boer, J. M. A. Pol, and S. H. M. Jeurissen, Proc.…”
mentioning
confidence: 99%
“…Vaccination of eggs represents a promising avenue of delivery, and over the past 2 decades it has been shown to be a safe, effective, and convenient method of administering many different agents, including drugs, nutrients, immunogens, and genes (11,31). In ovo administration of protein-based, as well as live or attenuated, vaccines has been experimentally demonstrated to be an effective method of immunization against many different avian diseases and is routinely performed in the commercial broiler industry for selected pathogens (6,21,30,(35)(36)(37)(38)44). In the case of coccidiosis, in ovo vaccination using live Eimeria parasites (45,46) has shown promising results for disease management in production settings, although a drawback to any immunization protocol using viable coccidia is posthatch fecal shedding of infectious oocysts.…”
mentioning
confidence: 99%
“…Such recombinant HVT-based vaccines confer excellent and long-lasting simultaneous protective immunity in chickens against more than one pathogen, following the "one stone, two birds" principle. [21][22][23][24] However, these HVT recombinants have been prepared using conventional genomic recombination techniques, which are extremely time-consuming and laborintensive. Additionally, it has never been possible to recover purified recombinant viruses through plaque selection methods, leading to decreased immunogenicity after continuous passage in cultured cells.…”
Section: Engineering Hvt As a Bivalent Vaccine For Avian Influenza Anmentioning
confidence: 99%